Cargando…
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach
BACKGROUND: The COVID-19 pandemic has increased the need for innovative quantitative decision tools to support rapid development of safe and efficacious vaccines against SARS-CoV-2. To meet that need, we developed and applied a model-based meta-analysis (MBMA) approach integrating non-clinical and c...
Autores principales: | Kandala, Bhargava, Plock, Nele, Chawla, Akshita, Largajolli, Anna, Robey, Seth, Watson, Kenny, Thatavarti, Raj, Dubey, Sheri A., Cheung, S.Y. Amy, de Greef, Rik, Stone, Julie, Sachs, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514977/ https://www.ncbi.nlm.nih.gov/pubmed/36182824 http://dx.doi.org/10.1016/j.ebiom.2022.104264 |
Ejemplares similares
-
1010. Cross-Species Translation of Correlates of Protection for COVID-19 Vaccine Candidates Using Quantitative Tools
por: Largajolli, Anna, et al.
Publicado: (2021) -
V(2)ACHER: Visualization of complex trial data in pharmacometric analyses with covariates
por: Lommerse, Jos, et al.
Publicado: (2021) -
Population pharmacokinetic analysis of the P2X3‐receptor antagonist gefapixant
por: Chawla, Akshita, et al.
Publicado: (2023) -
Bayesian approach to investigate a two-state
mixed model of COPD exacerbations
por: Largajolli, Anna, et al.
Publicado: (2019) -
Correction to: Bayesian approach to investigate a two-state mixed model of COPD exacerbations
por: Largajolli, Anna, et al.
Publicado: (2019)